Lipoproteins, HDL
This graph shows the total number of publications written about "Lipoproteins, HDL" by people in the URMC Research Network by year, and whether "Lipoproteins, HDL" was a major or minor topic of these publication.
Below are the most recent publications written about "Lipoproteins, HDL" by people in Profiles.
-
Corsetti JP, Gansevoort RT, Sparks CE, Dullaart RP. Inflammation reduces HDL protection against primary cardiac risk. Eur J Clin Invest. 2010 Jun; 40(6):483-9.
-
Lowenstein CJ, Cameron SJ. High-density lipoprotein metabolism and endothelial function. Curr Opin Endocrinol Diabetes Obes. 2010 Apr; 17(2):166-70.
-
Ma Y, Olendzki BC, Merriam PA, Chiriboga DE, Culver AL, Li W, Hébert JR, Ockene IS, Griffith JA, Pagoto SL. A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetes. Nutrition. 2008 Jan; 24(1):45-56.
-
Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008 Feb; 152(2):165-70.
-
Corsetti JP, Zareba W, Moss AJ, Rainwater DL, Sparks CE. Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation. Atherosclerosis. 2006 Jul; 187(1):191-7.
-
Redmond EM, Sitzmann JV, Cahill PA. Potential mechanisms for cardiovascular protective effect of ethanol. Acta Pharmacol Sin. 2000 May; 21(5):385-90.
-
Emond MJ, Zareba W. Prognostic value of cholesterol in women of different ages. J Womens Health. 1997 Jun; 6(3):295-307.
-
Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995 Jul; 15(7):821-6.
-
Jospe N, Orlowski CC, Furlanetto RW. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome. J Pediatr Endocrinol Metab. 1995 Apr-Jun; 8(2):111-6.
-
Lesnik P, Vonica A, Guérin M, Moreau M, Chapman MJ. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb. 1993 Jul; 13(7):1066-75.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
